New

AI v2.0 Beta Launched. Experience the future of pharmaceutical care.

Try Now
Drug info language
Switches all medical info on this page (labels, indications, leaflet) without changing the rest of the interface.
CNASHighly Regulated (List I)

STRESAM

50MG/Capsule/ETIFOXINE CHLORHYDRATE
BIOCODEX
ManufacturerVerified lab

BIOCODEX

Public retail price
262.84DZD

Identification

Active ingredient (INN)
ETIFOXINE CHLORHYDRATE
Internal code
16 B 093
Country of Origin
France
Pharmaceutical form
Capsule
Prescription List
Highly Regulated (List I)
Packaging
b/24 et b/60
STRESAM
Clinical View
CNAS
Highly Regulated (List I)

DAWA Clinical Workbench v2.0

Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.

Description

Etifoxine is an anxiolytic and anticonvulsant drug developed by Hoechst in the 1960s.

It is used in anxiety disorders and to promote peripheral nerve healing.

It does not bind to the benzodiazepine receptor though the effects are similar to that of benzodiazepines.

It is more effective than lorazepam as an anxiolytic, and has fewer side effects.

Etifoxine has been associated with acute liver injury.

Indications

Not Available

Adverse Effects

Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.

View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.

Alternatives